Previous 10 | Next 10 |
The following slide deck was published by Capricor Therapeutics, Inc. in conjunction with this Read more ...
LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online. Registration details and the company schedule can be seen here: https://ld500.ldmicro.co...
LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / Capricor Therapeutics ("Capricor") (NASDAQ:CAPR), a clinical-stage biotechnology company focused on the development of first-in-class cell and exosome-based therapeutics for the treatment and prevention of diseases, today announced that it w...
Dyne Therapeutics ( DYN ) has filed a preliminary prospectus for a $100M IPO. More news on: Dyne Therapeutics, Inc., Sarepta Therapeutics, Inc., Nippon Shinyaku Co. Ltd., Healthcare stocks news, IPO News, , Read more ...
– The INSPIRE Trial is a Randomized, Placebo-Controlled, Multi-Center Study Evaluating the Safety and Efficacy of Intravenous Infusion of CAP-1002 – – The Study Leverages Capricor’s Lead Asset, CAP-1002 Technology – LOS ANGELES, Aug. 25, ...
Capricor Therapeutics, Inc. (CAPR) Q2 2020 Earnings Conference Call August 06, 2020, 16:30 ET Company Participants Anthony Bergmann - CFO & Corporate Treasurer Linda Marbán - Co-Founder, President, CEO & Director Conference Call Participants Naureen Quibria - Max...
Gainers: Conduent (NASDAQ: CNDT ) +75% . More news on: Conduent Incorporated, OpGen, Inc., Groupon, Inc., Stocks on the move, , Read more ...
Capricor Therapeutics (NASDAQ: CAPR ) : Q2 GAAP EPS of -$0.23 beats by $0.11 . More news on: Capricor Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Exosome Platform for COVID-19 -Novel Multivalent Exosome mRNA and VLP Vaccine Candidates Underway in Animal Studies- -Preclinical Data Shows Positive Antibody Response- CAP-1002 for COVID-19 -Expanded Access Emergency Use Series Published in Peer Reviewed Journal- -Randomiz...
Sonnet BioTherapeutics (NASDAQ: SONN ) +118% . More news on: Sonnet BioTherapeutics Holdings, Inc., electroCore, Inc., Applied DNA Sciences, Inc., Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Capricor Therapeutics Inc. Company Name:
CAPR Stock Symbol:
NASDAQ Market:
Capricor Therapeutics Inc. Website:
SAN DIEGO, July 01, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced that the Company is set to join the Russell 2000 ® Index an...
-Results in Performance of the Upper Limb (PUL v2.0) Continue to Show Slowing of Disease Progression in Later-Stage DMD Patients- -Improvements Seen in Multiple Cardiac Endpoints Demonstrating Stabilization of Cardiac Function Over 3 Years of Treatment- -Pre-BLA Meeting with FDA...
SAN DIEGO, June 25, 2024 (GLOBE NEWSWIRE) -- In a release issued under the headline "Capricor Therapeutics Announces for the Treatment of Duchenne Muscular Dystrophy" on Tuesday, June 25th by Capricor Therapeutics, please note that the words "Pre-BLA Meeting with FDA for Deramiocel" were omitted ...